From a patient who recovered from COVID-19, scientists have isolated a pair of neutralising antibodies that could potentially block the virus responsible for the pandemic from entering into host cells. The study, published in the journal Science, suggests that a "cocktail" containing both antibodies could provide direct therapeutic benefits for COVID-19 patients.

From a patient who recovered from #COVID19, scientists have isolated a pair of neutralising antibodies that could potentially block the virus responsible for the pandemic from entering into host cells.#COVID #COVID19Pandemic pic.twitter.com/VbT3HZ6hVz